{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:23:24Z","timestamp":1648995804980},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,20]]},"DOI":"10.1097\/cm9.0000000000000437","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T15:11:12Z","timestamp":1569424272000},"page":"2498-2500","source":"Crossref","is-referenced-by-count":0,"title":["Complete response of myeloid\/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia\/myeloid sarcoma to imatinib monotherapy"],"prefix":"10.1097","volume":"132","author":[{"given":"Rui","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Song","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bjh.12742","article-title":"Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy","volume":"165","author":"Srinivas","year":"2014","journal-title":"Br J Haematol"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/ejh.12272","article-title":"Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy","volume":"92","author":"Barraco","year":"2014","journal-title":"Eur J Haematol"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cancergen.2017.07.007","article-title":"A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia\/lymphoma without eosinophilia","volume":"216\u2013217","author":"Oberley","year":"2017","journal-title":"Cancer Genet"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T12:37:09Z","timestamp":1612010229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,20]]},"references-count":4,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000437","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,20]]}}}